Inflammatory Bowel Disease: Current Status and Future Approach : Proceedings of the International Symposium on Future Research Approaches to Inflammatory Bowel Disease, Mechanisms of Chronic Infection and Inflammation, Fort Lauderdale, Florida, USA, October 7-11, 1987Richard P. MacDermott |
From inside the book
Results 1-3 of 90
Page 242
... inhibition of monocyte - accessory cell func- tion ) . This possibility was less likely due to the findings in 2 experiments . First , T84 factor could be absorbed out by incubat- ing supernatant ( 3 % ) with 20x106 T cells for one hour ...
... inhibition of monocyte - accessory cell func- tion ) . This possibility was less likely due to the findings in 2 experiments . First , T84 factor could be absorbed out by incubat- ing supernatant ( 3 % ) with 20x106 T cells for one hour ...
Page 305
... inhibition * ASA 6.5 SP 1.4 IND no inhibition 0.3 > 15 0.001 Effects of drugs on PGE2 release were evaluated during the basal , effects on cysteinyl - LT release during the ionophore - stimulated incubation period . * For effect of SA ...
... inhibition * ASA 6.5 SP 1.4 IND no inhibition 0.3 > 15 0.001 Effects of drugs on PGE2 release were evaluated during the basal , effects on cysteinyl - LT release during the ionophore - stimulated incubation period . * For effect of SA ...
Page 311
... Inhibition 84.5 .001 PGE2 50 mg / Kg Inhibition 62.3 .001 PGI2 0.1 μg / Kg Inhibition 55.2 .005 TXB2 10 μg / Kg Exacerbation 53.7 .006 * Agonist given IV 1 min prior to IV PG - APS ( 5 μg rhamnose / g bw ) † P values < 0.006 comparing ...
... Inhibition 84.5 .001 PGE2 50 mg / Kg Inhibition 62.3 .001 PGI2 0.1 μg / Kg Inhibition 55.2 .005 TXB2 10 μg / Kg Exacerbation 53.7 .006 * Agonist given IV 1 min prior to IV PG - APS ( 5 μg rhamnose / g bw ) † P values < 0.006 comparing ...
Contents
Defect in immunoregulatory intestinal epithelial cells in inflammatory | 9 |
Vasoactive intestinal peptide and the severity of colonic inflammation | 25 |
Substance P andor calcitonin generelated peptide are present | 43 |
Copyright | |
8 other sections not shown
Other editions - View all
Common terms and phrases
acid activity addition analysis animals antibodies antigen approach assay associated bacterial binding blood cell cultures changes chronic Clin clinical colon compared concentrations containing Crohn's disease culture cytotoxicity decreased demonstrated described detected determined Division effect epithelial cells examined experiments expression factor Figure function future Gastroenterology growth human immune Immunol increased incubated indicate induced infection inflammation inflammatory bowel disease inhibition intestinal isolated jejunum lamina propria levels lymph nodes lymphocytes MacDermott macrophages mean measured mechanisms mediators METHODS mice mucosal mycobacteria normal observed obtained occurred organisms patients positive prepared present previously production protein Publishers rats receptor REFERENCES release reported response role samples Science secretion sera serum showed shown significant similar specific specimens status stimulated strain studies suggest supported synthesis Table tested tissue ulcerative colitis vitro